Chemfab Alkalis Share Price
Sector: Chemical Manufacturing
821.00 -26.35 (-3.11%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
785.50
Today’s High
848.05
52 Week Low
502
52 Week High
1229.50
814.05 -34.25 (-4.04%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
780.90
Today’s High
864
52 Week Low
500.45
52 Week High
1230
Key Metrics
- Market Cap (In Cr) 1183.06
- Beta 0.7
- Div. Yield (%) 0.15
- P/B 3.21
- TTM P/E -
- Peg Ratio -
- Sector P/E 17.45
- D/E 0
- Open Price 848.05
- Prev Close 847.35
Chemfab Alkalis Analysis
Price Analysis
-
1 Week-2.88%
-
3 Months0.96%
-
6 Month-8.81%
-
YTD-17.31%
-
1 Year30.3%
Risk Meter
- 51% Low risk
- 51% Moderate risk
- 51% Balanced Risk
- 51% High risk
- 51% Extreme risk
Chemfab Alkalis News
Q4 results today: Tata Power, Eicher Motors, Lupin, Shree Cements on May 14
1 min read . 14 May 20255 stocks that stand to benefit from govt's decision to curb soda ash import
7 min read . 06 Jan 2025Chemfab Alkalis Financials
- INCOME
- BALANCE SHEET
- Cashflow
- Period
- 2025
- Total Revenue
- 334.37
- Selling/ General/ Admin Expenses Total
- 25.51
- Depreciation/ Amortization
- 36.33
- Other Operating Expenses Total
- 46.69
- Total Operating Expense
- 336.87
- Operating Income
- -2.5
- Net Income Before Taxes
- -0.31
- Net Income
- -6.94
- Diluted Normalized EPS
- -0.36
- Period
- 2025
- Total Assets
- 521.82
- Total Liabilities
- 141.83
- Total Equity
- 379.99
- Tangible Book Valueper Share Common Eq
- 264.52
- Period
- 2025
- Period
- 2024
- Total Revenue
- 327.3
- Selling/ General/ Admin Expenses Total
- 25.84
- Depreciation/ Amortization
- 22.35
- Other Operating Expenses Total
- 26.75
- Total Operating Expense
- 295.6
- Operating Income
- 31.7
- Net Income Before Taxes
- 39.15
- Net Income
- 26.32
- Diluted Normalized EPS
- 18.34
- Period
- 2024
- Total Assets
- 500.32
- Total Liabilities
- 113.06
- Total Equity
- 387.26
- Tangible Book Valueper Share Common Eq
- 272.17
- Period
- 2024
- Cashfrom Operating Activities
- 31.35
- Cashfrom Investing Activities
- -109.53
- Cashfrom Financing Activities
- 16.06
- Net Changein Cash
- -62.11
- Period
- 2023
- Total Revenue
- 331.36
- Selling/ General/ Admin Expenses Total
- 22.09
- Depreciation/ Amortization
- 22.93
- Other Operating Expenses Total
- 24.23
- Total Operating Expense
- 247.27
- Operating Income
- 84.09
- Net Income Before Taxes
- 89.44
- Net Income
- 64.58
- Diluted Normalized EPS
- 46.86
- Period
- 2023
- Total Assets
- 412.1
- Total Liabilities
- 50.74
- Total Equity
- 361.35
- Tangible Book Valueper Share Common Eq
- 254.77
- Period
- 2023
- Cashfrom Operating Activities
- 92.59
- Cashfrom Investing Activities
- -47.51
- Cashfrom Financing Activities
- -8.89
- Net Changein Cash
- 36.19
- Period
- 2022
- Total Revenue
- 271.59
- Selling/ General/ Admin Expenses Total
- 22.39
- Depreciation/ Amortization
- 22.22
- Other Operating Expenses Total
- 17.38
- Total Operating Expense
- 237.22
- Operating Income
- 34.37
- Net Income Before Taxes
- 39.1
- Net Income
- 28.75
- Diluted Normalized EPS
- 20.74
- Period
- 2022
- Total Assets
- 352.18
- Total Liabilities
- 54.18
- Total Equity
- 298
- Tangible Book Valueper Share Common Eq
- 210.78
- Period
- 2022
- Cashfrom Operating Activities
- 54.91
- Cashfrom Investing Activities
- -21.03
- Cashfrom Financing Activities
- -24.57
- Net Changein Cash
- 9.31
- Period
- 2021
- Total Revenue
- 180.81
- Selling/ General/ Admin Expenses Total
- 26.31
- Depreciation/ Amortization
- 20.22
- Other Operating Expenses Total
- 10.64
- Total Operating Expense
- 177.3
- Operating Income
- 3.51
- Net Income Before Taxes
- 2.03
- Net Income
- -8.13
- Diluted Normalized EPS
- -5.81
- Period
- 2021
- Total Assets
- 334.92
- Total Liabilities
- 67.6
- Total Equity
- 267.33
- Tangible Book Valueper Share Common Eq
- 190.02
- Period
- 2021
- Cashfrom Operating Activities
- 45.43
- Cashfrom Investing Activities
- -6.43
- Cashfrom Financing Activities
- -15.59
- Net Changein Cash
- 23.41
- Period
- 2020
- Total Revenue
- 204.52
- Selling/ General/ Admin Expenses Total
- 23.4
- Depreciation/ Amortization
- 25.09
- Other Operating Expenses Total
- 13.77
- Total Operating Expense
- 174.29
- Operating Income
- 30.23
- Net Income Before Taxes
- 26.71
- Net Income
- 25.45
- Diluted Normalized EPS
- 20.16
- Period
- 2020
- Total Assets
- 348.37
- Total Liabilities
- 72.84
- Total Equity
- 275.53
- Tangible Book Valueper Share Common Eq
- 197.54
- Period
- 2020
- Cashfrom Operating Activities
- 54.23
- Cashfrom Investing Activities
- -58.14
- Cashfrom Financing Activities
- 2.91
- Net Changein Cash
- -1.01
- Period
- 2019
- Total Revenue
- 193.19
- Selling/ General/ Admin Expenses Total
- 16.7
- Depreciation/ Amortization
- 14.92
- Other Operating Expenses Total
- 22.23
- Total Operating Expense
- 167.44
- Operating Income
- 25.75
- Net Income Before Taxes
- 28.48
- Net Income
- 16.76
- Diluted Normalized EPS
- 19.95
- Period
- 2019
- Total Assets
- 320.99
- Total Liabilities
- 69.88
- Total Equity
- 251.11
- Tangible Book Valueper Share Common Eq
- 180.55
- Period
- 2019
- Cashfrom Operating Activities
- 40.99
- Cashfrom Investing Activities
- -46.62
- Cashfrom Financing Activities
- 5.82
- Net Changein Cash
- 0.19
- Period
- 2025-03-31
- Total Revenue
- 92.32
- Selling/ General/ Admin Expenses Total
- 6.14
- Depreciation/ Amortization
- 10.61
- Other Operating Expenses Total
- 12.65
- Total Operating Expense
- 99.48
- Operating Income
- -7.16
- Net Income Before Taxes
- -7.35
- Net Income
- -9.19
- Diluted Normalized EPS
- -1.93
- Period
- 2025-03-31
- Total Assets
- 521.82
- Total Liabilities
- 141.83
- Total Equity
- 379.99
- Tangible Book Valueper Share Common Eq
- 264.52
- Period
- 2025-03-31
- Period
- 2024-12-31
- Total Revenue
- 83.62
- Selling/ General/ Admin Expenses Total
- 6.3
- Depreciation/ Amortization
- 9.62
- Other Operating Expenses Total
- 10.72
- Total Operating Expense
- 81.33
- Operating Income
- 2.29
- Net Income Before Taxes
- 3.64
- Net Income
- 1.88
- Diluted Normalized EPS
- 1.32
- Period
- 2024-12-31
- Period
- 2024-12-31
- Period
- 2024-09-30
- Total Revenue
- 81.9
- Selling/ General/ Admin Expenses Total
- 6.89
- Depreciation/ Amortization
- 8.8
- Other Operating Expenses Total
- 11.09
- Total Operating Expense
- 80.55
- Operating Income
- 1.34
- Net Income Before Taxes
- 0.73
- Net Income
- -0.53
- Diluted Normalized EPS
- -0.37
- Period
- 2024-09-30
- Total Assets
- 534.45
- Total Liabilities
- 148.05
- Total Equity
- 386.4
- Tangible Book Valueper Share Common Eq
- 271.57
- Period
- 2024-09-30
- Period
- 2024-06-30
- Total Revenue
- 76.53
- Selling/ General/ Admin Expenses Total
- 6.18
- Depreciation/ Amortization
- 7.31
- Other Operating Expenses Total
- 12.24
- Total Operating Expense
- 75.51
- Operating Income
- 1.02
- Net Income Before Taxes
- 2.67
- Net Income
- 0.9
- Diluted Normalized EPS
- 0.62
- Period
- 2024-06-30
- Period
- 2024-06-30
- Period
- 2024-03-31
- Total Revenue
- 82.31
- Selling/ General/ Admin Expenses Total
- 5.62
- Depreciation/ Amortization
- 5.86
- Other Operating Expenses Total
- 9.28
- Total Operating Expense
- 75.85
- Operating Income
- 6.46
- Net Income Before Taxes
- 7.96
- Net Income
- 5.41
- Diluted Normalized EPS
- 3.76
- Period
- 2024-03-31
- Total Assets
- 500.32
- Total Liabilities
- 113.06
- Total Equity
- 387.26
- Tangible Book Valueper Share Common Eq
- 272.17
- Period
- 2024-03-31
- Cashfrom Operating Activities
- 31.35
- Cashfrom Investing Activities
- -109.53
- Cashfrom Financing Activities
- -2.44
- Net Changein Cash
- -62.11
- Period
- 2023-12-31
- Total Revenue
- 86.33
- Selling/ General/ Admin Expenses Total
- 5.85
- Depreciation/ Amortization
- 5.45
- Other Operating Expenses Total
- 9.85
- Total Operating Expense
- 76.58
- Operating Income
- 9.75
- Net Income Before Taxes
- 10.83
- Net Income
- 7.1
- Diluted Normalized EPS
- 4.95
- Period
- 2023-12-31
- Period
- 2023-12-31
Forecast
Income Sheet (In Cr)
Net Income Vs Revenue
Returns Metrics (In Cr)
ROA Vs ROE
Forecast
Balance Sheet
Asset vs Liability
Forecast
Cash Flow
Operating vs Investing
Chemfab Alkalis Technical
Moving Average
SMA
- 5 Day852.41
- 10 Day835.18
- 20 Day821.69
- 50 Day792.39
- 100 Day870.87
- 300 Day930.3
Chemfab Alkalis Peers
- Price
- Ratio
- Name
- Latest Price
- Change
- % Change
- 52W High
- 52W Low
- Mkt. Cap
- Amines & Plasticizers
- 219.2
- 2
- 0.92
- 359
- 178.6
- 1206.04
- Gulshan Polyols
- 192.2
- -1.1
- -0.57
- 262.95
- 143.15
- 1198.76
- Chemfab Alkalis
- 821
- -26.35
- -3.11
- 1229.5
- 502
- 1183.06
- Tgv Sraac
- 107
- -0.95
- -0.88
- 120.9
- 74.19
- 1145.86
- Heranba Industriesord
- 291.3
- 5.7
- 2
- 561
- 205.2
- 1165.6
- Name
- P/E (X)
- P/B (X)
- ROE %
- OPM
- Amines & Plasticizers
- 30.52
- 5.52
- 19.3
- 5.43
- Gulshan Polyols
- 68.49
- 2.05
- 10.39
- 4.58
- Chemfab Alkalis
- -
- 3.17
- 6.37
- 7.24
- Tgv Sraac
- 38.54
- 1.05
- 17.06
- 8.53
- Heranba Industriesord
- 32.62
- 1.35
- 19.95
- 9.36
Chemfab Alkalis Shareholding
Shareholding Pattern
Shareholding Trend
Shareholding(%) v/s Date
Corporate Actions
- Board Meeting
- AGM
- Dividends
- Bonus
- Split
- Rights
- Meeting Date
- Purpose
- 14-May-25
- Audited Results & Final Dividend
- 30-Jan-25
- Quarterly Results
- 04-Nov-24
- Quarterly Results
- 08-Aug-24
- Quarterly Results
- 22-May-24
- Audited Results, Final Dividend & ESOP
- 08-Feb-24
- Quarterly Results
- 26-Oct-23
- Quarterly Results
- 27-Jul-23
- Quarterly Results & ESOP
- 18-May-23
- Audited Results, Final Dividend & ESOP
- 07-Feb-23
- Quarterly Results & ESOP
- Meeting Date
- Announced on
- Purpose
- 20-Sept-24
- 30-Aug-24
- AGM
- 29-Aug-23
- 07-Aug-23
- AGM
- 22-Apr-22
- 30-Mar-22
- EGM
- 04-Aug-21
- 21-Jun-21
- AGM
- Announced on
- Record Date
- Ex-Dividend
- Dividend Value
- 14-May-25
- -
- -
- 1.25
- 22-May-24
- -
- 13-Sept-24
- 1.25
- 18-May-23
- -
- 22-Aug-23
- 1.25
- 25-May-22
- -
- 07-Sept-22
- 1.25


